feed,title,long_url,short_url
Benzinga,"Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails",https://benzinga.com/general/biotech/24/06/39333999/pharma-stock-roundup-fda-panel-endorses-llys-donanemab-pfes-dmd-therapy-study-fails,https://da.gd/tZve97
